Abstract
Cannabinoid CB1 receptors have been implicated in the antinociceptive effect of paracetamol. In the current study, we examined whether blockade of CB1 receptors prevent the analgesic activity of dipyrone, in a similar way to paracetamol. Hot-plate and tail-flick tests were used to assess the antinociceptive activity in mice. Dipyrone and WIN 55,212-2, a cannabinoid agonist, exerted significant antinociceptive effects in both hot-plate and tail flick tests. The CB1 receptor antagonist, AM-251 (3 mg/kg), at a dose which had no effect when used alone, did not alter the antinociceptive effect of dipyrone, whereas completely prevented the antinociceptive activity of WIN 55,212-2 in both thermal antinociceptive tests. Our findings suggest that, unlike paracetamol, cannabinoid CB1 receptors do not participate in the antinociceptive action of dipyrone when acute pain tests used.
Similar content being viewed by others
References
Akman H, Aksu F, Gultekin I, Ozbek H, Oral U, Doran F, Baysal F (1996) A possible central antinociceptive effect of dipyrone in mice. Pharmacology 53:71–78
Beirith A, Santos ARS, Rodrigues ALS, Creczynski-Pasa TB, Calixto JB (1998) Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action. Eur J Pharmacol 345:233–245
Bujalska M (2004) Effect of nonselective and selective opioid receptors antagonists on antinociceptive action of APAP [Part III]. pol J Pharmacol 56:539–545
Campos C, De Gregorio R, Garcia-Nieto R, Gago F, Ortiz P, Alemany S (1999) Regulation of cyclooxygenase activity by metamizol. Eur J Pharmacol 378:339–347
Dani M, Guindon J, Lambert C, Beaulieu P (2007) The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors. Eur J Pharmacol 573:214–215
Dogrul A, Seyrek M, Yalcin B, Ulugol A (2012) Involvement of descending serotonergic and noradrenergic pathways in cannabinoid CB1 receptor-mediated antinociception. Prog Neurpsychopharmacol Biol Psychiatry 38:97–105. doi:10.1016/j.pnpbp.2012.01.007
Escobar W, Ramirez K, Avila C, Limongi R, Vanegas H, Vazquez E (2012) Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats. Eur J Pain 16:676–689. doi:10.1002/j.1532-2149.2011.00057.x
Gunduz O, Karadag HC, Ulugol A (2011a) Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice. Pharmacol Biochem Behav 99:540–544. doi:10.1016/j.pbb.2011.05.029
Gunduz O, Oltulu C, Guven R, Buldum D, Ulugol A (2011b) Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats. Neurol Sci 32:1135–1142. doi:10.1007/s10072-011-0761-7
Gunduz O, Oltulu C, Ulugol A (2011c) Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the beta-lactam antibiotic, ceftriaxone, in mice. Pharmacol Biochem Behav 99:100–103. doi:10.1016/j.pbb.2011.04.012
Hernandez N, Vanegas H (2001) Antinociception induced by PAG-microinjected dipyrone (metamizol) in rats: involvement of spinal endogenous opioids. Brain Res 896:175–178
Hernandez-Delgadillo GP, Cruz SL (2006) Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats. Eur J Pharmacol 546:54–59
Isguzar O, Baris S, Bozkurt A, Can B, Bilge S, Ture H (2012) Evaluation of antinociceptive and neurotoxic effects of intrathecal dexmedetomidine in rats. Balkan Med J 29:354–357. doi:10.5152/balkanmedj.2012.034
Lorenzetti BB, Ferreira SH (1996) Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia. Inflamm Res 45:308–311
Mallet C, Daulhac L, Bonnefont J, Ledent C, Etienne M, Chapuy E, Libert F, Eschalier A (2008) Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain 139:190–200. doi:10.1016/j.pain.2008.03.030
Neugebauer V, Schaible HG, He X, Lücke T, Gündling P, Schmidt RF (1994) Electrophysiological evidence for a spinal antinociceptive action of dipyrone. Agents Actions 41:62–70
Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A (2006) The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol 531:280–281
Rogosch T, Sinning C, Podlewski A, Watzer B, Schlosburg J, Lichtman AH, Cascio MG, Bisogno T, Di Marzo V, Nüsing R, Imming P (2012) Novel bioactive metabolites of dipyrone (metamizol). Bioorgan Med Chem 20:101–107. doi:10.1016/j.bmc.2011.11.028
Sandrini M, Vitale G, Ottani S, Pini L (2001) The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. Biochem Pharmacol 61:1409–1416
Schlosburg JE, Kinsey SG, Lichtman AH (2009) Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflmmation. AAPS J 11:39–44. doi:10.1208/s12248-008-9075-y
Schlosburg JE, Radanova L, Di Marzo V, Imming P, Lichtman AH (2012) Evaluation of the endogenous cannabinoid system in mediating the behavioral effects of dipyrone (metamizol) in mice. Behav Pharmacol 23:722–726. doi:10.1097/FBP.0b013e3283584794
Seyrek M, Kahraman S, Deveci MS, Yesilyurt O, Dogrul A (2010) Systemic cannabinoids produce CB1-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT7 and 5-HT2A receptors. Eur J Pharmacol 649:183–194. doi:10.1016/j.ejphar.2010.09.039
Siebel JS, Beirith A, Calixto JB (2004) Evidence for the involvement of metabotropic glutamatergic, neurokinin 1 receptor pathways and protein kinase C in the antinociceptive effect of dipyrone in mice. Brain Res 1003:61–67
Taylor J, Mellström B, Fernaud I, Naranjo JR (1998) Metamizol potentiates morphine effects on visceral pain and evoked c-Fos immunoreactivity in spinal cord. Eur J Pharmacol 351:39–47
Ulugol A, Karadag HC, Ipci Y, Tamer M, Dokmeci I (2004) The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats. Neurosci Lett 371:167–170
Ulugol A, Ozyigit F, Yesilyurt O, Dogrul A (2006) The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac. Anesth Analg 102:443–447
Vanegas H, Schaible HG (2001) Prostaglandins and cyclooxygenases in the spinal cord. Prog Neurobiol 64:327–363
Vanegas H, Tortorici V (2002) Opioidergic effects of nonopioid analgesics on the central nervous system. Cell Mol Neurobiol 5–6:655–661
Vasquez E, Vanegas H (2000) The antinociceptive effect of PAG-microinjected dipyrone in rats is mediated by endogenous opioids of the rostral ventromedial medulla. Brain Res 854:249–252
Vazquez E, Hernandez N, Escobar W, Vanegas H (2005) Antinociception induced by intravenous dipyrone (metamizol) upon dorsal horn neurons: involvement of endogenous opioids at the periaqueductal gray matter, the nucleus raphe magnus, and the spinal cord in rats. Brain Res 1048:211–217
Vazquez E, Escobar W, Ramirez K, Vanegas H (2007) A nonopioid analgesic acts upon the PAG-RVM axis to reverse inflammatory hyperalgesia. Eur J Neurosci 25:471–479
Yilmaz I, Ulugol A (2009) The effect of nitric oxide synthase inhibitors on the development of analgesic tolerance to dipyrone in mice. Int J Neurosci 119:755–764. doi:10.1080/00207450902776192
Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109–110
Acknowledgments
This work was supported by a grant from Trakya University Research Council (TUBAP-2012/58). The authors have no conflicts of interests to report.
Author information
Authors and Affiliations
Corresponding author
Additional information
Submitted to “Pain in Europe VIII, 8th Congress of the European Federation of IASP Chapters”, Florence, Italy, 9–12 October, 2013.
Rights and permissions
About this article
Cite this article
Elmas, P., Ulugol, A. Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone. J Neural Transm 120, 1533–1538 (2013). https://doi.org/10.1007/s00702-013-1052-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-013-1052-7